Ranbaxy to launch a new anti-malarial drug India.Com Health 'Phase III clinical trials for the drug, conducted in India successfully demonstrated the efficacy and tolerability of Synriam as comparable to chloroquine,' the company said in a statement. The company is looking to make the drug available in African ... |
